- Dr. Parravano Mariacristina (Responsible of Operating Unit)
- Dr. Boninfante Antonluca
- Dr. Chiaravalloti Adele
- Dr. De Geronimo Daniele
- Dr. Giorno Paola
- Dr. Iacono Pierluigi
- Dr. Scarinci Fabio
- Dr. Sciamanna Marta
- Dr. Tedeschi Massimiliano
- Dr. Costanzo Eliana
- Dr. Casale Ilaria*
- Dr. Giannotti Marta*
- Dr. Lioi Susanna *
- Dr. Sebastiani Chiara *
- Dr. Armento Simone *
- Dr. Bellelli Ilaria *
The macula is the area of the retina responsible for visual acuity. The pathologies that affect it are the cause of progressive loss of vision, which can sometimes be complete and irreversible. Some of the most frequent macular disorders, which also have a significant socio-economic impact, include age-related macular degeneration and diabetic maculopathy. Of equal concern are myopic macular degeneration, hereditary maculopathies, and disorders of the vitreoretinal interface. Diabetic retinopathy is the main ocular complication of diabetes mellitus, and in industrialized countries it is the number one cause of legal blindness in people of working age. Epidemiological data show that 30% of the diabetic population suffers from retinopathy, and that every year 1% of them are struck with the most severe forms of this disease. Blindness caused by diabetic retinopathy can be avoided in over half of all cases if patients are correctly informed and subjected to early screening, and if suitable health education norms are implemented. Current guidelines are aimed mainly at prevention - through the study of etiopathogenic mechanisms and the identification of risk factors – and at experimenting with new forms of treatment, such as the intravitreal injection of anti-VEGF drugs.
- Morpho-functional studies, treatment options, and assessment of the quality of vision through functional and psychometric tests in patients affected by age-related and myopic macular degeneration.
- Study of the morpho-functional alterations and options for treatment and rehabilitation in diabetic retinopathy and retinal vein occlusion.
- Studies onin vivo and in vitro models of vascular retinal pathologies.
- Screening project for the main retinal pathologies.
- Imaging and other diagnostic approaches to retinal pathologies.
- Treatment of neovascularizations other than secondary ones to senile and myopic maculopathy.
- Assessment of the physiopathological mechanisms of vascular retinal pathologies
- Validation of diagnostic methodologies in retinal pathology